Paul R. Edick
See Remarks at Xeris Biopharma Holdings Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Xeris Biopharma Holdings Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Xeris Biopharma Holdings Inc. June 5, 202490.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 31, 2024 | Xeris Biopharma Holdings Inc. | Grant or award | +1,500,000 | — | — |
| Aug 9, 2023 | Xeris Biopharma Holdings Inc. | Open-market purchase | +10,000 | $2.38 | $23,800 |
| Jan 31, 2023 | Xeris Biopharma Holdings Inc. | Grant or award | +750,000 | — | — |
Questions about Paul R. Edick
What boards is Paul R. Edick on?
Paul R. Edick sits on the boards of Vistagen Therapeutics Inc. and Xeris Biopharma Holdings Inc.
How long has Paul R. Edick served on boards?
Our records show at least 5 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.